Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SeaStar Medical Holding CorpICU · Entity 7863 | Interim CFO | September 22, 2023 | November 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SeaStar Medical Holding Corp
Report date September 22, 2023 · Filed November 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 139,872 |
Last balance in matching sequence
After 2023-11-29 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-09-22 · Other · Acquired 15,070 · Balance 119,579 F1: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person. F2: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4. Row 2 · 2023-11-29 · Grant · Acquired 20,293 · Balance 139,872 F3: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. F2: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.84 · Expires 2033-04-06 | Direct | 16,621 |
Reported balance
Holding disclosure · report date 2023-09-22 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 16,621 F4: All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2030-03-20 | Direct | 4,796 |
Reported balance
Holding disclosure · report date 2023-09-22 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 4,796 F5: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 30, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 30, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.55 · Expires 2031-01-01 | Direct | 19,685 |
Reported balance
Holding disclosure · report date 2023-09-22 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 19,685 F6: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from January 1, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person.
F2: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4.
F3: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.
F4: All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant.
F5: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 30, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 30, 2021.
F6: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from January 1, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 1, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2023 Filed Nov 29, 2023 16:14 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 20,293 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-003300 · form4.xml · nonDerivative · entry 2 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,872 F3 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. F2 · balance_after: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4. Read SEC document |
| September 22, 2023 Filed Nov 29, 2023 16:14 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | OtherCommon Stock, par value $0.0001 per share | 15,070 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-003300 · form4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,579 F1 · kind: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person. F1 · shares: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person. F2 · balance_after: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 19:48 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 4,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-002569 · form4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,506 F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Read SEC document |
| August 31, 2023 Filed Sep 12, 2023 20:09 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 3,374 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-002511 · form4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,396 F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 17:21 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 | 2,031 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-002300 · form4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,022 F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:01 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | Tax withholdingCommon Stock, par value $0.0001 per share | 15,070 | $0.53 | $7,949.43 |
DisclosureSEC source: 0000929638-23-001717 · form4.xml · nonDerivative · entry 2 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,991 F3 · shares: Represents shares withheld to satisfy tax withholding obligations. F2 · balance_after: Includes 53,192 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:01 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 56,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-001717 · form4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,061 F1 · shares: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. F2 · balance_after: Includes 53,192 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:11 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantStock Option (Right to Buy) · Derivative | 16,621 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0000929638-23-001152 · form4.xml · derivative · entry 2 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,621 Underlying: Common Stock · 16,621 shares Expires 2033-04-06 F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:11 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 11,080 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-001152 · form4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,192 F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 16:15 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantStock Option (Right to Buy) · Derivative | 19,685 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0000899243-22-034688 · doc4.xml · derivative · entry 3 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,685 Underlying: Common Stock · 19,685 shares Expires 2031-01-01 F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option to purchase shares of SeaStar Medical common stock was assumed and converted into an option to purchase shares of common stock of the Issuer with the same terms and conditions as were applicable to such option immediately prior to the Effective Time, subject to the applicable exchange ratio. F4 · derivative.exercise_date: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from January 1, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 1, 2022. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 16:15 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantStock Option (Right to Buy) · Derivative | 4,796 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034688 · doc4.xml · derivative · entry 2 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,796 Underlying: Common Stock · 4,796 shares Expires 2030-03-20 F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option to purchase shares of SeaStar Medical common stock was assumed and converted into an option to purchase shares of common stock of the Issuer with the same terms and conditions as were applicable to such option immediately prior to the Effective Time, subject to the applicable exchange ratio. F3 · derivative.exercise_date: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 30, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 30, 2021. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 16:15 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 42,112 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034688 · doc4.xml · nonDerivative · entry 1 Baron Caryl · CIK 0001949735 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,112 F1 · kind: Represents the Issuer's common stock subject to restricted stock units (RSUs). Pursuant to the Agreement and Plan of Merger by and among the Issuer, LMF Merger Sub, Inc., and SeaStar Medical Inc. ("SeaStar Medical"), dated April 21, 2022 (as amended, the "Merger Agreement"), at the Effective Time (as defined in the Merger Agreement), each award of RSUs based on SeaStar Medical common stock that was outstanding immediately prior to the Effective Time was converted into the right to receive RSUs based on the common stock of the Issuer with the same terms and conditions as were applicable to such SeaStar Medical RSU awards immediately prior to the Effective Time, subject to the applicable exchange ratio. Fifty percent (50%) of the shares subject to RSUs reported herein will vest on the first anniversary of the Effective Time, thereafter the remaining will vest on a monthly basis over a 24-month period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.